Patients Support

The Institute for Protection of Immunodeficiency Patients was established on August 13^th, 2018 with the mission of providing comprehensive support for immunodeficiency patients in areas of prevention, diagnosis, treatment at the individual and social levels.

Founders:

Dr. Mostafa Moein
Dr. Zahra Pourpak
Dr. Masoud Movahedi
Dr. Mohammad Reza Fazlollahi
Dr. Abolfazl Golestani
Dr. Bahman Shahmohammadi
Dr. Maryam Nourizadeh
Dr. Maryam Ayyazi
Ms. Marzieh Sallek

Please follow the link below for more information:

http://en.idpa.org.ir/

اطلاعیه‌ها

Scientific News

Special look

IAARI Faculty Attend the 2023 HAEi Regional Conference EMEA

A team of faculty members from IAARI participated in 2023 HAEi Regional Conference EMEA. Hereditary angioedema (HAE) a rare and potentially life-threatening disease that causes severe swelling of the throat and suffocation. The conference was held in Munich, Germany from September 1 to 3, 2023.

World Hereditary Angioedema Day Commemorated at IAARI

IAARI organized a webinar to commemorate the World Hereditary Angioedema Day (HAE Day) on May 15, 2023. The webinar featured speeches from professors of clinical immunology and allergy from Tehran University of Medical Sciences and Iran University of Medical Sciences

How IAARI Helps Patients with Rare Immune Disorders: An Interview with Dr. Fazlollahi

In an interview with Dr. Mohammadreza Fazlollahi, the deputy of the center, he explains how IAARI provides various services for these patients, such as specialized laboratory tests, genetic counseling, stem cell transplantation, supportive care, and international collaboration.

Primary immunodeficiency diseases: why early and accurate diagnosis matters

During World Primary Immunodeficiency Week (April 22-29), Dr. Mohammad Reza Fazlollahi, the deputy of the Immunology, Asthma, and Allergy Research Institute (IAARI), was interviewed by the institute's Public Relations team. The interview focused on primary immunodeficiency diseases, specifically discussing their prevalence, severity, symptoms, and treatments.